Jichang Han, BS, is the first at Dartmouth to receive a Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) from the National Cancer Institute (NCI) of the National Institutes of Health (NIH).
Post Tagged with: "Norris Cotton Cancer Center"
Researchers in the laboratory of Mary Jo Turk, PhD, Co-Director of the Immunology and Cancer Immunotherapy Research Program at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center have spent the past year studying immunity to metastatic cancer within lymph nodes.
Now entering its second year, the Dartmouth Innovations Accelerator for Cancer has attracted more than $3.5 million in philanthropy and has helped 17 research teams advance their work. In this video researchers from the winning teams describe how the Accelerator is advancing their innovations.
The 40th Prouty concluded this weekend with a record-breaking success of raising more than $4 million in support of cancer research and patient and family support services at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC).
Researchers at Norris Cotton Cancer Center have developed a way to predict chemotherapy response to tailor treatments for pancreatic cancer patients.
Dartmouth researchers achieve better long-term control of drug-resistant breast cancer growth in mice by switching between estrogen and anti-estrogen therapies.
Researchers at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC) have found that a certain subpopulation of cells that enters a patient’s skin and blood during immunotherapy is behind the excellent and long-lasting immune responses to cancer that some survivors develop.
Dartmouth researchers convert a standard linear accelerator used for delivery of radiation therapy cancer treatment, to deliver an ultra-high-dose rate radiation therapy beam to patients “in a flash.”
Lionel D. Lewis, MD, MA, MB BCh, has been elected as a fellow of the British Pharmacological Society, a premier global society in the science of pharmacology.
Dartmouth College alumni and health care investors have committed a total of $1.4 million in gifts to launch the Dartmouth Innovations Accelerator for Cancer which will allow for innovations to the marketplace for the benefit of cancer patients, and provide Dartmouth students with learning opportunities in biomedical entrepreneurship.